Ipsen SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ipsen SA with three other
companies in this sector in France:
sales of 871.83 million Euro [US$1.03 billion]
of which 58%
was Companion Animals),
(775.77 million Euro [US$912.67 million]
of which 48%
was X-rays), and
(614.49 million Euro [US$722.93 million]
of which 51%
was Non-Proprietary Homeopathic Medicines).
Ipsen SA reported sales of 1.67 billion Euro (US$1.97 billion)
December of 2016.
increase of 9.9%
versus 2015, when the company's sales were 1.52 billion Euro.
Sales at Ipsen SA have increased during each of the previous five years
(and since 2011, sales have increased a total of 44%).
Sales of Specialty Care saw an increase
14.3% in 2016, from
1.11 billion Euro to 1.27 billion Euro.
Not all segments of Ipsen SA experienced an increase in sales in 2016:
sales of Primary Care fell 5.5% to 311.60 million Euro.